Radiotherapy and Oncology

Papers
(The H4-Index of Radiotherapy and Oncology is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Contents164
Call For Papers: Radiotherapy & Oncology and The Lancet Oncology collaboration126
529 Current standard of care treatment in non-metastatic cervix cancer118
44 Ultrahypofractionated Versus Moderately Hypofractionated and Conventionally Fractionated Pelvic Radiotherapy for Prostate Cancer: Outcomes from 3 Prospective Clinical Trials100
80 Stereotactic Body Radiation Therapy for Intrahepatic Graft Recurrence of Hepatocellular Carcinoma After Liver Transplantation97
292 Correlation of cf DNA with response in head & neck cancer treated with definitive chemoradiotherapy90
122 Effect of Different Treatment Planning Optimizers on Stereotactic Ablation Radiotherapy (SABR) Volumetric Modulated ARC Therapy (VMAT) Plans83
23 Stereotactic Body Versus Conventional Fractionation External Beam Radiotherapy (EBRT) Boost for High-Risk Prostate Cancer (HR-PC); Early Results of PBS: A Phase II Randomized Trial (NCT03380806)78
31 Program Director Perspectives on the Implementation and Experiences of the Competence By Design Curriculum in Canadian Radiation Oncology Training Programs78
525 Proton and carbon therapy: recent technological advances77
33 An investigator-initiated clinical study using SBRT as “in situ vaccination”:‘R-ISV-FOLactis’trial74
54 Scattered Radiation to the Testis and Testosterone Secretion in Prostate Cancer Treated with Radiotherapy Alone73
45 Stereotactic radiosurgery for tremor: a center experience.73
Corrigendum to “Parallel explorations in LA-NSCLC: Chemoradiation dose-response optimisation considering immunotherapy and cardiac toxicity sparing” [Radiother. Oncol. 200 (2024) 110477]72
207 ctDNA-based WES enhances actionable alterations detection in locally advanced head and neck cancer71
157 Adaptive radiation therapy66
480 Addressing the education and training needs of RTT in particle radiation therapy64
937: Prediction of the dose-averaged proton linear energy transfer using convolutional neural networks64
2076: RapidBrachyIVBT: A dosimetry software for personalized image-guided intravascular brachytherapy57
3007: SABR prior to liver transplantation in HCC patients: a 10 years’ experience56
158: Validation of intrafraction prostate drift corrections on a 1.5T MR-linac using cine-MRI55
3050: Impact of a philanthropic online course about cervical cancer on the learning outcome55
2030: Impact & usability of virtual reality on emotional wellbeing of sarcoma patients:VR-SARC study54
1086: Urethra-sparing single-dose ablative prostate radiotherapy with real-time motion management52
3429: Modulating innate immunity by DNA damage response inhibition51
1583: Phantom-based optimization of virtual monoenergetic image reconstruction in dual-energy CT51
749: Reinforcement learning for accelerated automatic treatment planning optimization50
1232: Modern era radical radiotherapy toxicity: a preliminary CONCORDE analysis of the calibration arm50
1062: Micro-dissected tumour tissues-on-chip; a tool for translational radiation oncology50
2975: UHRT in PCa: a clinical and toxicity impact analysis from real world experience.49
204: PET-CT DenseNet outperforms advanced DL models for outcome prediction of oropharyngeal cancer49
1635: In vivo dosimetry - keeping my finger on the pulse48
1861: Performance of a heart substructures autocontouring tool after clinical implementation47
2486: Impact of patient specific deep learning OAR segmentation on accumulated online adapted MRgRT dose47
687: Hearing loss after cranial radiation in children: a dosimetry study from the French registry PediaRT47
3201: Dosimetric properties of flexible 3D-printed boluses46
1933: High-resolution Diode array vs film for QA of trigeminal neuralgia treatments with Cyberknife46
2607: Carbon footprint reduction with the adoption of hypofractionation in a public health facility45
941: Should Varian HyperArc make us re-think how we use conventional linacs for SRS?45
1962: Study protocol B-REST: respiratory und relaxation training in adjuvant radiotherapy of breast cancer43
2311: Treatment plan robustness in IMPT for esophageal cancer: every millimeter counts.43
1487: Radiotherapy access in the Asia-Pacific: Are we making progress for low- & middle-income countries?42
1432: Comparative study of various homogeneity indices in SIB-VMAT planning for head and neck tumors.42
0.16958785057068